Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Hypertension

1594

Hypertension is an intermittent or persistent elevation of the blood pressure. It is widely believed to be one of the most important risk factors for death from stroke, congestive heart failure, and coronary heart disease (CHD) and coupled with its high and rising prevalence, is thus considered a major health threat. This is significant, since, according to the CDC, heart disease and stroke are the number one and three causes of death in the United States, accounting for more than 40% of all deaths.

Although these largely preventable conditions are more common among people aged 65 and older, the number of sudden deaths from heart disease among people aged 15 to 34 has increased. This increase is partially attributable to a more sedentary lifestyle which is causing Americans’ waistlines to expand. Studies have shown that as weight goes up, so does the incidence of hypertension. Just 14.9% of normal weight men and 15.2% of normal weight women have hypertension, this rises to 41.9% for obese men and 37.8% of obese women.

Hypertension is largely treatable through lifestyle modifications. Although in some sufferers, the disease is linked to genetics and other factors beyond the patient’s control, changes in diet, exercise and/or smoking can significantly reduce disease severity for many people. There are also numerous classes of drugs available to lower blood pressure, the most common of which are diuretics, beta-blockers, calcium-channel blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers, and alpha one antagonists.

RSS Feeds

All reports in Hypertension

< prev 1  2  3  next >
Pulmonary Arterial Hypertension – Pipeline Review, H1 2012
4/19/2012 | published by: Global Markets Direct
... the therapeutic development for Pulmonary Arterial Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pulmonary Arterial Hypertension. 'Pulmonary Arterial ...  |  more...
$500.00
Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
3/31/2012 | published by: GlobalData
... Analysis to 2020”, an essential and comprehensive source of information and analysis on the global Pulmonary Arterial Hypertension (PAH) therapeutics market. The report identifies and analyzes the key trends shaping and driving the global PAH ...  |  more...
$6,995.00
Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion
3/23/2012 | published by: GBI Research
... 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion”, which provides insights into the anti-hypertensives therapeutics market until 2017. The report is built using data and information sourced ...  |  more...
$3,500.00
Diabetic Hypertension – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Diabetic Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Hypertension. 'Diabetic Hypertension - Pipeline Review, H1 2012' ...  |  more...
$500.00
Ocular Hypertension – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Ocular Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ocular Hypertension. 'Ocular Hypertension - Pipeline Review, H1 2012' ...  |  more...
$500.00
Disease State Management Strategies I. Clinical Guidelines for Primary Care
3/1/2012 | published by: Apollo Managed Care Consultants
... related patient ed handouts + resource materials helpful for accreditation and to reduce variation while improving outcomes. Extensive references, resource materials, and related web sites are listed for all guidelines . Valuable evidence-based tools for ...  |  more...
$275.00
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
2/29/2012 | published by: GlobalData
... is an essential source of information and analysis on the global Portal Hypertension Therapeutics market. The report identifies the key trends shaping and driving the global Portal Hypertension Therapeutics market. The report also provides insights ...  |  more...
$3,995.00
Hypertension – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypertension. 'Hypertension - Pipeline Review, H1 2012' is built using data and information ...  |  more...
$500.00
Hypertension Global Clinical Trials Review, H1, 2012
1/31/2012 | published by: GlobalData
... to the clinical trials on Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of ...  |  more...
$1,000.00
Pulmonary Hypertension Global Clinical Trials Review, H1, 2012
1/27/2012 | published by: GlobalData
... and data relating to the clinical trials on Pulmonary Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Anti-Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2018
11/3/2011 | published by: GlobalData
... essential source of information and analysis on the global Anti-hypertension Therapeutics market. The report identifies the key trends shaping and driving the global Anti-hypertension Therapeutics market. The report also provides insights on the prevalent competitive ...  |  more...
$3,500.00
UAE Healthcare Sector Forecast to 2012
11/1/2011 | published by: RNCOS
... diseases (obesity, diabetes, and hypertension), epidemic outbreaks like H1N1, and the lack of internationally accredited healthcare infrastructure. According to our new research report, "UAE Healthcare Sector Forecast to 2012", the UAE healthcare industry is expected ...  |  more...
$1,000.00
China Hypertension Prescription Drug Sales Data 2007-2010
11/1/2011 | published by: Draco Healthcare Consulting LLC
... and drug purchasing data from extensive hospital coverage in 16 major cities and more than 300 hospitals. Sampled hospitals are from major Chinese cities across different geographic locations, including Beijing, Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, ...  |  more...
$8,000.00
Diabetic Hypertension - Pipeline Review, H2 2011
10/26/2011 | published by: Global Markets Direct
... for Diabetic Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Hypertension. 'Diabetic Hypertension - Pipeline Review, H2 2011' ...  |  more...
$500.00
Hypertension - Pipeline Review, H2 2011
9/28/2011 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypertension. 'Hypertension - Pipeline Review, H2 2011' is built using data and information ...  |  more...
$500.00
Pulmonary Arterial Hypertension - Pipeline Review, H2 2011
8/31/2011 | published by: Global Markets Direct
... the therapeutic development for Pulmonary Arterial Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pulmonary Arterial Hypertension. 'Pulmonary Arterial ...  |  more...
$500.00
21st European Meeting on Hypertension and Cardiovascular Prevention 2011 - Post-Conference Review and Analysis
6/30/2011 | published by: GlobalData
... - Post-Conference Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies and new disease management techniques. 21st European Meeting on Hypertension and Cardiovascular Prevention 2011 was ...  |  more...
$1,000.00
Diabetic Hypertension - Pipeline Review, Q1 2011
3/29/2011 | published by: Global Markets Direct
... for Diabetic Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Hypertension. 'Diabetic Hypertension - Pipeline Review, Q1 2011' ...  |  more...
$500.00
European Market for Nutritional Solutions in Immune and Antihypertensive Health
3/22/2011 | published by: Frost & Sullivan
... position in their relevant market segments is analyzed. It provides revenue forecasts at a total market and segment level from 2010 to 2016, challenges affecting the industry, factors driving growth of the market, competitive scenario ...  |  more...
$6,800.00
Hypertension Therapy Area Pipeline Report
3/14/2011 | published by: Life Science Analytics (LSA)
... a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and ...  |  more...
$1,495.00
Pulmonary Hypertension Therapy Area Pipeline Report
3/14/2011 | published by: Life Science Analytics (LSA)
... as well as a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, ...  |  more...
$1,495.00
Hypertension - Pipeline Review, Q1 2011
2/28/2011 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypertension. 'Hypertension - Pipeline Review, Q1 2011' is built using data and information ...  |  more...
$500.00
Commercial Insight: Cardiovascular and Metabolic Market Forecast
2/8/2011 | published by: Datamonitor
... sales; however, the heavy genericization of the hypertension and dyslipidemia primary care markets will lead to the overall market decreasing by -0.5% in the seven major markets. Features and benefits Gain insight into the cardiovascular ...  |  more...
$15,200.00
Withdrawal of Sitaxentan (Thelin) Creates Huge Unmet Need in the Pulmonary Arterial Hypertension (PAH) Market
2/4/2011 | published by: GlobalData
... Hypertension (PAH) Market” provides key data, information on PAH Market. Scope Data and information on noval therapy on PAH market Reasons to buy Develop business strategies by understanding the trends and developments in PAH Market  |  more...
$500.00
Hypertension Global Clinical Trials Review, Q1, 2011
1/31/2011 | published by: GlobalData
... to the clinical trials on Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by ...  |  more...
$1,000.00
< prev 1  2  3  next >